Moderna pushes forward on Respiratory Syncytial Virus vaccine
Moderna and Merck are also collaborating on a specialized cancer vaccine.
A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020(photo credit: REUTERS/BRIAN SNYDER)ByCODY LEVINE
